Navigation Links
Forest Laboratories, Inc. and Merz Pharma GmbH & Co. KgaA File Additional Lawsuit Against Several Companies for Patent Infringement
Date:1/25/2008

NEW YORK, Jan. 25 /PRNewswire-FirstCall/ -- Forest Laboratories, Inc. (NYSE: FRX), Forest Laboratories Holdings, Ltd., Merz Pharma GmbH & Co. KgaA, and Merz Pharmaceuticals GmbH announced that they have filed a second lawsuit in the U.S. District Court for the District of Delaware against additional companies for infringement of U.S. Patent No. 5,061,703 (the '703 patent), which relates to Forest's Namenda(R) product. The defendants named in the lawsuit include Dr. Reddy's Laboratories Limited, Genpharm Inc., Interpharm Inc., Mylan Pharmaceuticals Inc., Ranbaxy Laboratories Limited, Sun India Pharmaceutical Industries Limited, and related companies and subsidiaries thereof. The '703 patent expires in April 2010. Forest has applied for patent term extension which, if granted, would extend the '703 patent until September 2013.

(Logo: http://www.newscom.com/cgi-bin/prnh/20001011/FORESTLOGO )

As previously reported, Forest and Merz had received notification from several companies that they had filed Abbreviated New Drug Applications with Paragraph IV certifications to obtain approval to market generic versions of Namenda and commenced an action in patent infringement in the U.S. District Court in Delaware against such filers.

Except for the historical information contained herein, this release contains forward-looking statements within the meaning of the Private Securities Litigation Reform act of 1995. These statements involve a number of risks and uncertainties, including the difficulty of predicting FDA approvals, the acceptance and demand for new pharmaceutical products, the impact of competitive products and pricing, the timely develop
'/>"/>

SOURCE Forest Laboratories, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Forest and Cypress Announce Submission of New Drug Application for Milnacipran for the Treatment of Fibromyalgia Syndrome
2. BioSpace Launches 3rd Edition of BioForest(TM) Bioscience Marketing Campaign
3. Drugs from Johnson & Johnson/Basilea and Forest Are the Most Promising Antibiotics in the Community-Acquired Pneumonia Pipeline
4. Nanotube forests grown on silicon chips for future computers, electronics
5. Forest Laboratories Lexapro and Generics-Dominated Fluoxetine Lead First-Line Therapy in the Treatment for Major Depression
6. Microbia and Forest Laboratories Announce Linaclotide Co-Development and Co-Marketing Collaboration
7. Forest Laboratories Announces Federal Appeals Court Upholds Lexapro(R) Patent Decision
8. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Methimazole Tablets USP, 5 mg and 10 mg
9. Octapharma Joins Biotechnology Industry Organization
10. Arena Pharmaceuticals Announces Initiation of Phase 1 Clinical Trial of Second Generation Niacin Receptor Agonist Under Its Collaboration With Merck & Co., Inc.
11. Aton Pharma Introduces Expanded Distribution of Lacrisert(R) (hydroxypropyl cellulose ophthalmic insert) at Hawaiian Eye

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...-- Biotech firm Replikins Ltd., which has analyzed...ic through the prediction, outbreak, and progress ...est biochemical analysis of the virus. The new dat...") virus has dropped from its peak of 3.7 (s.d. 4....ng of 2009 to resting non-epidemic levels this wee...
(Date:11/25/2009)... Cytochroma today announced the appointment of Pet... will replace Mr. Ulrik Spork as the Novo A/S repr...oard members remains unchanged at six members. ,...the board and look forward to benefiting from his ... make progress in becoming a leading CKD-focused s...
(Date:11/25/2009)...stCall/ -- Ardea Biosciences, Inc. (Nasdaq: RDEA ...resident and chief executive officer, will present...erence. , ,Presentation details are as follows:,...ate: Tuesday, December 1, 2009,Time: 2:0... Hotel, New York, NY,Webcast: <a href=,http://t...
(Date:11/24/2009)...sit Detroit , (Vocus) Nov...bassador for International Investment, and Chairma...What: Ambassador Appia is available to meet with p...opted by France to further develop the financial, ...evelopment., , ,When: Available for Interview on W...
Breaking Biology Technology:Biological H1N1 Vaccines: Too Little, Too Late 2Biological H1N1 Vaccines: Too Little, Too Late 3Biological H1N1 Vaccines: Too Little, Too Late 4Biological H1N1 Vaccines: Too Little, Too Late 5Cytochroma Announces Appointment of Peter Moldt to Board of Directors 2Ardea Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference 2
...on, Inc. (Nasdaq: MDVN ) today announced that ...agement to discuss first quarter 2009 financial re...day, May 11, 2009, at 4:30 p.m. Eastern Time. A p... 2009 will be released after markets close on May ...-3376 from the U.S. or +1-719-325-4757 internation...
... Congressional Black Caucus Spring Health Braintru...misinformed about Alzheimer,s but support a screen... American and Hispanic adults are more concerned a...out prevention of and risk factors than Caucasians...by Eisai, Inc. Dr. Sharon Richardson, vice presid...
...Group at Frost & Sullivan is pleased to anno...ion on the Global Active Pharmaceutical Ingredient...09, at 3 p.m. GMT. , , (Logo: http://www.newscom...arket, traditionally dominated by small molecule d...s biopharmaceuticals. At the same time the manufac...
Other Biology Technology:Medivation Announces First Quarter 2009 Financial Results Teleconference and Webcast on May 11, 2009 2New Survey Reveals Gap in Understanding of Alzheimer's Disease Risk and Prevention Among Most Vulnerable Populations 2New Survey Reveals Gap in Understanding of Alzheimer's Disease Risk and Prevention Among Most Vulnerable Populations 3New Survey Reveals Gap in Understanding of Alzheimer's Disease Risk and Prevention Among Most Vulnerable Populations 4The Global Active Pharmaceutical Ingredients (API) Market: A Frost & Sullivan Briefing on Changing Dynamics 2The Global Active Pharmaceutical Ingredients (API) Market: A Frost & Sullivan Briefing on Changing Dynamics 3
(Date:11/23/2009)..., TORONTO, November 23, 2009 - The time of day m...ding to a new paper produced by a research team le...onto Scarborough,s vice-principal for research and...biology at the St. George campus. , Capitalizi...the poplar tree, the research team examined how po...
(Date:11/23/2009)... Farmington, CT Current research suggests that a...isease. The related report by Nichols et al, "Uni... a New Class of TLR2 Ligands Capable of Enhancing ...of The American Journal of Pathology . , Multip...em attacks the brain and spinal cord, affects near...
(Date:11/23/2009)... LIVERMORE, Calif. - By producing some of the hig...neral surfaces, scientists have a deeper understan...ls. This research may lead to a new treatment for ..., which appears in the Nov. 23 online edition of t... Sciences , explores how peptides interact with mi...
Breaking Biology News(10 mins):Time of day matters to thirsty trees, U of T researcher discovers 2Factors from common human bacteria may trigger multiple sclerosis 2Scientists watch as peptides control crystal growth with 'switches, throttles and brakes' 2Scientists watch as peptides control crystal growth with 'switches, throttles and brakes' 3Navigaitor Helps Patients Walk Again 49126 1Navigaitor Helps Patients Walk Again 49126 2Navigaitor Helps Patients Walk Again 49126 3Navigaitor Helps Patients Walk Again 49126 4Navigaitor Helps Patients Walk Again 49126 5URAC and CARF International Announce New Survey Tool for Health Care Case Management Studies 49124 1URAC and CARF International Announce New Survey Tool for Health Care Case Management Studies 49124 2URAC and CARF International Announce New Survey Tool for Health Care Case Management Studies 49124 3URAC and CARF International Announce New Survey Tool for Health Care Case Management Studies 49124 4Assurant Employee Benefits Adds New Voluntary Capabilities 49122 1Assurant Employee Benefits Adds New Voluntary Capabilities 49122 2
... development could aid the treatment, and in some ...n babies in intensive care. , By providing vital i...he scanner avoids the need to move critically ill ...may involve sedating them and has a degree of risk... to diagnose and assess conditions such as brain h...
...regulatory gene that shows clear evidence of evolu...evolution of humans might well have depended in pa...phin (PDYN), that plays critical roles in regulati...d that, compared to lower primates, humans possess...the prodynorphin gene, which is a precursor molecu...
...nal of Experimental Medicine identifies a small ge... active tuberculosis (TB). Pedro Flores-Villanuev...alth Center (Tyler, TX) studied groups of patients...o carry this genetic change were more likely to de...ia. , Infections with Mycobacterium tuberculosis, ...
Other Biology News:New brain scan technology could save babies' lives 2Key brain regulatory gene shows evolution in humans 2Key brain regulatory gene shows evolution in humans 3Key brain regulatory gene shows evolution in humans 4Gene increases risk of tuberculosis 2
Goat Anti-HAS1 Polyclonal Antibody, Unconjugated from Santa Cruz Biotechnology, Inc.
Frozen Tissue Section Panel - Monkey (Rhesus) Normal Tissue, Multi-tissue I from BioChain
Frozen Tissue Section Panel - Monkey (Cynomolgus) Normal Tissue, Multi-tissue I from BioChain
MEGAscript RNAi Kit from Ambion
Biology Products: